Basic Information
Proteros biostructures GmbH is a privately-owned early-stage drug discovery service provider dedicated to helping pharmaceutical and biotechnology companies unlock even the most challenging drug targets. A pioneer in the industrialization of structural biology, Proteros has developed a cutting-edge drug discovery platform encompassing protein science, protein crystallography, cryo-electron microscopy, analytics, biophysics, and screening, positioned to open doors for technically demanding targets and lead optimization and clinical programs.
Proteros biostructures GmbH
Germany
51~100 people
January 01, 1998
--

